Selective targeting of KRAS-Mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-Mutant cells

Toshifumi Hara, Matthew F. Jones, Murugan Subramanian, Xiao Ling Li, Oliver Ou, Yuelin Zhu, Yuan Yang, Lalage M. Wakefield, S. Perwez Hussain, Jochen Gaedcke, Thomas Ried, Ji Luo, Natasha J. Caplen, Ashish Lal

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

MicroRNAs (miRNAs) regulate the expression of hundreds of genes. However, identifying the critical targets within a miRNA-regulated gene network is challenging. One approach is to identify miRNAs that exert a context-dependent effect, followed by expression profiling to determine how specific targets contribute to this selective effect. In this study, we performed miRNA mimic screens in isogenic KRAS-Wild-type (WT) and KRAS-Mutant colorectal cancer (CRC) cell lines to identify miRNAs selectively targeting KRAS-Mutant cells. One of the miRNAs we identified as a selective inhibitor of the survival of multiple KRAS-Mutant CRC lines was miR-126. In KRAS-Mutant cells, miR-126 over-expression increased the G1 compartment, inhibited clonogenicity and tumorigenicity, while exerting no effect on KRAS-WT cells. Unexpectedly, the miR-126-regulated transcriptome of KRAS-WT and KRAS-Mutant cells showed no significant differences. However, by analyzing the overlap between miR-126 targets with the synthetic lethal genes identified by RNAi in KRAS-Mutant cells, we identified and validated a subset of miR-126-regulated genes selectively required for the survival and clonogenicity of KRAS-Mutant cells. Our strategy therefore identified critical target genes within the miR-126-regulated gene network. We propose that the selective effect of miR-126 on KRAS-Mutant cells could be utilized for the development of targeted therapy for KRAS mutant tumors.

Original languageEnglish
Pages (from-to)7635-7650
Number of pages16
JournalOncotarget
Volume5
Issue number17
DOIs
Publication statusPublished - 1 Jan 2014
Externally publishedYes

Fingerprint

Essential Genes
MicroRNAs
Gene Regulatory Networks
Colorectal Neoplasms
Lethal Genes
Synthetic Genes
RNA Interference
Transcriptome
Genes
Gene Expression
Cell Line
Neoplasms

Keywords

  • Colorectal cancer
  • KRAS
  • KRAS mutant
  • miR-126
  • miRNA

ASJC Scopus subject areas

  • Oncology

Cite this

Selective targeting of KRAS-Mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-Mutant cells. / Hara, Toshifumi; Jones, Matthew F.; Subramanian, Murugan; Li, Xiao Ling; Ou, Oliver; Zhu, Yuelin; Yang, Yuan; Wakefield, Lalage M.; Perwez Hussain, S.; Gaedcke, Jochen; Ried, Thomas; Luo, Ji; Caplen, Natasha J.; Lal, Ashish.

In: Oncotarget, Vol. 5, No. 17, 01.01.2014, p. 7635-7650.

Research output: Contribution to journalArticle

Hara, T, Jones, MF, Subramanian, M, Li, XL, Ou, O, Zhu, Y, Yang, Y, Wakefield, LM, Perwez Hussain, S, Gaedcke, J, Ried, T, Luo, J, Caplen, NJ & Lal, A 2014, 'Selective targeting of KRAS-Mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-Mutant cells', Oncotarget, vol. 5, no. 17, pp. 7635-7650. https://doi.org/10.18632/oncotarget.2284
Hara, Toshifumi ; Jones, Matthew F. ; Subramanian, Murugan ; Li, Xiao Ling ; Ou, Oliver ; Zhu, Yuelin ; Yang, Yuan ; Wakefield, Lalage M. ; Perwez Hussain, S. ; Gaedcke, Jochen ; Ried, Thomas ; Luo, Ji ; Caplen, Natasha J. ; Lal, Ashish. / Selective targeting of KRAS-Mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-Mutant cells. In: Oncotarget. 2014 ; Vol. 5, No. 17. pp. 7635-7650.
@article{0cab76b7a467411bb32231f3855aea77,
title = "Selective targeting of KRAS-Mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-Mutant cells",
abstract = "MicroRNAs (miRNAs) regulate the expression of hundreds of genes. However, identifying the critical targets within a miRNA-regulated gene network is challenging. One approach is to identify miRNAs that exert a context-dependent effect, followed by expression profiling to determine how specific targets contribute to this selective effect. In this study, we performed miRNA mimic screens in isogenic KRAS-Wild-type (WT) and KRAS-Mutant colorectal cancer (CRC) cell lines to identify miRNAs selectively targeting KRAS-Mutant cells. One of the miRNAs we identified as a selective inhibitor of the survival of multiple KRAS-Mutant CRC lines was miR-126. In KRAS-Mutant cells, miR-126 over-expression increased the G1 compartment, inhibited clonogenicity and tumorigenicity, while exerting no effect on KRAS-WT cells. Unexpectedly, the miR-126-regulated transcriptome of KRAS-WT and KRAS-Mutant cells showed no significant differences. However, by analyzing the overlap between miR-126 targets with the synthetic lethal genes identified by RNAi in KRAS-Mutant cells, we identified and validated a subset of miR-126-regulated genes selectively required for the survival and clonogenicity of KRAS-Mutant cells. Our strategy therefore identified critical target genes within the miR-126-regulated gene network. We propose that the selective effect of miR-126 on KRAS-Mutant cells could be utilized for the development of targeted therapy for KRAS mutant tumors.",
keywords = "Colorectal cancer, KRAS, KRAS mutant, miR-126, miRNA",
author = "Toshifumi Hara and Jones, {Matthew F.} and Murugan Subramanian and Li, {Xiao Ling} and Oliver Ou and Yuelin Zhu and Yuan Yang and Wakefield, {Lalage M.} and {Perwez Hussain}, S. and Jochen Gaedcke and Thomas Ried and Ji Luo and Caplen, {Natasha J.} and Ashish Lal",
year = "2014",
month = "1",
day = "1",
doi = "10.18632/oncotarget.2284",
language = "English",
volume = "5",
pages = "7635--7650",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "17",

}

TY - JOUR

T1 - Selective targeting of KRAS-Mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-Mutant cells

AU - Hara, Toshifumi

AU - Jones, Matthew F.

AU - Subramanian, Murugan

AU - Li, Xiao Ling

AU - Ou, Oliver

AU - Zhu, Yuelin

AU - Yang, Yuan

AU - Wakefield, Lalage M.

AU - Perwez Hussain, S.

AU - Gaedcke, Jochen

AU - Ried, Thomas

AU - Luo, Ji

AU - Caplen, Natasha J.

AU - Lal, Ashish

PY - 2014/1/1

Y1 - 2014/1/1

N2 - MicroRNAs (miRNAs) regulate the expression of hundreds of genes. However, identifying the critical targets within a miRNA-regulated gene network is challenging. One approach is to identify miRNAs that exert a context-dependent effect, followed by expression profiling to determine how specific targets contribute to this selective effect. In this study, we performed miRNA mimic screens in isogenic KRAS-Wild-type (WT) and KRAS-Mutant colorectal cancer (CRC) cell lines to identify miRNAs selectively targeting KRAS-Mutant cells. One of the miRNAs we identified as a selective inhibitor of the survival of multiple KRAS-Mutant CRC lines was miR-126. In KRAS-Mutant cells, miR-126 over-expression increased the G1 compartment, inhibited clonogenicity and tumorigenicity, while exerting no effect on KRAS-WT cells. Unexpectedly, the miR-126-regulated transcriptome of KRAS-WT and KRAS-Mutant cells showed no significant differences. However, by analyzing the overlap between miR-126 targets with the synthetic lethal genes identified by RNAi in KRAS-Mutant cells, we identified and validated a subset of miR-126-regulated genes selectively required for the survival and clonogenicity of KRAS-Mutant cells. Our strategy therefore identified critical target genes within the miR-126-regulated gene network. We propose that the selective effect of miR-126 on KRAS-Mutant cells could be utilized for the development of targeted therapy for KRAS mutant tumors.

AB - MicroRNAs (miRNAs) regulate the expression of hundreds of genes. However, identifying the critical targets within a miRNA-regulated gene network is challenging. One approach is to identify miRNAs that exert a context-dependent effect, followed by expression profiling to determine how specific targets contribute to this selective effect. In this study, we performed miRNA mimic screens in isogenic KRAS-Wild-type (WT) and KRAS-Mutant colorectal cancer (CRC) cell lines to identify miRNAs selectively targeting KRAS-Mutant cells. One of the miRNAs we identified as a selective inhibitor of the survival of multiple KRAS-Mutant CRC lines was miR-126. In KRAS-Mutant cells, miR-126 over-expression increased the G1 compartment, inhibited clonogenicity and tumorigenicity, while exerting no effect on KRAS-WT cells. Unexpectedly, the miR-126-regulated transcriptome of KRAS-WT and KRAS-Mutant cells showed no significant differences. However, by analyzing the overlap between miR-126 targets with the synthetic lethal genes identified by RNAi in KRAS-Mutant cells, we identified and validated a subset of miR-126-regulated genes selectively required for the survival and clonogenicity of KRAS-Mutant cells. Our strategy therefore identified critical target genes within the miR-126-regulated gene network. We propose that the selective effect of miR-126 on KRAS-Mutant cells could be utilized for the development of targeted therapy for KRAS mutant tumors.

KW - Colorectal cancer

KW - KRAS

KW - KRAS mutant

KW - miR-126

KW - miRNA

UR - http://www.scopus.com/inward/record.url?scp=84907484056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907484056&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.2284

DO - 10.18632/oncotarget.2284

M3 - Article

VL - 5

SP - 7635

EP - 7650

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 17

ER -